Abstract
Editorial Note Atherosclerotic cardiovascular disease (ASCVD) is a leading global health concern, signiϐicantly contributing to acute cardiovascular events such as myocardial infarction and ischemic stroke. Research consistently links elevated levels of low-density lipoprotein cholesterol (LDL-C) to ASCVD. Preventive measures and early interventions can mitigate the disease’s progression [1]. Yet, despite advancements in medical treatments and the known beneϐits of lifestyle modiϐications like exercise and reduced saturated fat intake, ASCVD mortality rates continue to rise globally. Modern medical practices often fall short of eradicating ASCVD risk, emphasizing the need for more precise and proactive approaches. Delayed or inappropriate care ampliϐies the risk and complications of ASCVD, urging the necessity for improved preventive guidelines and risk assessment tools.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Research International Journal of Cardiology and Cardiovascular Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
